Common Contracts

UNDERWRITING AGREEMENT ROYALTY PHARMA PLC [●] Class A Ordinary Shares Underwriting Agreement

Underwriting Agreement • October 13th, 2020 • Royalty Pharma PLC • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  October 13th, 2020
• Company
  Royalty Pharma PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Certain shareholders named in Schedule 2 hereto (the “Selling Shareholders”) of Royalty Pharma plc, an English public limited company incorporated under the laws of England and Wales (the “Company”) propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] Class A Ordinary Shares (collectively, the “Underwritten Shares”), par value $0.0001 per share, of the Company (the “Class A Ordinary Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [●] Class A Ordinary Shares of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The Class A Ordinary Shares to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Globant S.A. [_________] Common Shares Underwriting Agreement

Underwriting Agreement • July 3rd, 2014 • Globant S.A. • Services-computer processing & data preparation • New York

• Contract Type
  Underwriting Agreement
• Filed
  July 3rd, 2014
• Company
  Globant S.A.
• Industry
  Services-computer processing & data preparation
• Jurisdiction
  New York

Globant S.A. (the “Company”), a société anonyme organized under the laws of the Grand Duchy of Luxembourg (“Luxembourg”), having its registered office at 5, rue Guillaume Kroll, L-1882 Luxembourg, registered with the Luxembourg Trade and Companies Register under number B 173 727, proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [_____] common shares, nominal value U.S.$1.20 per share (the “Common Shares”), of the Company, and certain shareholders of the Company identified in paragraph (a) of Schedule 2 hereto (the “Selling Shareholders I”) and the shareholders of the Company identified in paragraph (b) of Schedule 2 hereto (the “Selling Shareholders II” and, together with the Selling Shareholders I, the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [_______] Common Shares of the Company (collectively, the “Unde